Calcitriol acts via its receptor (VDR) and inhibits PTH secretion and parathyroid cell proliferation. Increased prevalence of the polymorphic VDR alleles b, a, and T has been demonstrated in sporadic primary hyperparathyroidism. Sixty-two patients with primary hyperparathyroidism due to parathyroid adenoma (mean age, 69.5 Ϯ 1.4 yr) were genotyped for these VDR polymorphisms. Dispersed cells of the adenomas were exposed to increasing concentrations of extracellular Ca 2ϩ and analyzed for PTH release and cytoplasmic Ca 2ϩ con- ] i ) seems to be an important second messenger in this process (4, 6, 7). However, mutations in the Ca 2ϩ receptor gene have not been found in parathyroid tumors of sporadic primary HPT (8).
centrations. Ca 2ϩ -mediated PTH inhibition exhibited higher ED 50 and less suppression in the cells of patients who were homozygous for the b, a, and T alleles (P Ͻ 0.05-0.10). When analyzing haplotypes, the patients with baT demonstrated a ED 50 of 1.81 Ϯ 0.15 vs. 1.29 Ϯ 0.10 for BAt (P Ͻ 0.05). As VDR alleles were unrelated to parathyroid intracellular Ca 2ϩ , influences of polymorphic VDR alleles on PTH secretion seem to involve mechanisms other than the Ca 2ϩ -sensing protein of the parathyroid cell surface. (J Clin Endocrinol Metab 82: 1772-1775, 1997) P RIMARY hyperparathyroidism (HPT) exhibits 1-3% prevalence in postmenopausal Swedish women (1, 2) . The abnormal parathyroid tissue characteristically demonstrates enhanced ED 50 in the inverse sigmoidal relationship between external Ca 2ϩ and PTH secretion and reduced calcium-mediated suppression of the secretion (3, 4) . This action of extracellular Ca 2ϩ involves Ca 2ϩ -sensing receptors on the parathyroid cell surface (5) , and the cytoplasmic Ca 2ϩ concentration ([Ca 2ϩ ] i ) seems to be an important second messenger in this process (4, 6, 7) . However, mutations in the Ca 2ϩ receptor gene have not been found in parathyroid tumors of sporadic primary HPT (8) .
Calcitriol is a principal regulator of both PTH secretion and proliferation of parathyroid cells (9 -11) . Calcitriol acts via its receptor (VDR), and the ligand-bound complex can inhibit PTH gene transcription by binding to vitamin D-responsive elements (12) . VDR dysfunction has been implicated in the pathogenesis of both primary and secondary HPT (13, 14) . Some studies, but not all, support the idea that linked polymorphisms in intron 8 (B/b and A/a alleles) and exon 9 (T/t alleles) of the VDR gene may relate to bone mineral density and the risk of developing osteoporosis (15, 16) . Increased prevalence of the VDR b, a, and T alleles in patients with sporadic primary HPT suggests that these polymorphisms may comprise a risk factor in the development of this disorder (17) (18) (19) . Experimental studies on minigene constructs support this idea by suggesting that the VDR haplotype baT relates to reduced VDR gene transcription and/or stability of its messenger ribonucleic acid (mRNA) (15) . The present study indicates relationships between VDR polymorphisms and Ca 2ϩ regulation of PTH release in primary HPT.
Subjects and Methods Subjects
Sixty-two consecutive patients (56 women and 6 men) with primary HPT due to surgically verified parathyroid adenoma were included in the study. Twenty-two of the patients were detected at population-based screening, as described previously (17) . None of the patients had a history of familial hypercalcemia or signs of multiple endocrine neoplasia syndromes. All individuals failed to demonstrate substantially increased serum creatinine values (Ͼ160 mol/L; reference range, 64 -106 mol/L) or postoperatively persistent hypercalcemia during follow-up for 1.1-4.5 yr (mean, 2.4 yr). Total serum calcium (reference range, 2.20 -2.60 mmol/L) and intact serum PTH (reference range, 12-55 ng/L) were determined as previously described (17) . All patients gave informed consent to participate in the study, which was approved by the local ethical committee.
DNA analysis
Genomic DNA was prepared from whole blood according to standard methods or from parathyroid adenomas (17) . VDR genotypes denoted BB, Bb, and bb were determined after Bsm 1 restriction cleavage of genomic DNA amplified by PCR, as previously reported (15, 17) . A 740-bp fragment of the VDR gene, including the ApaI and TaqI restriction sites in intron 8 and exon 9, was amplified using specific primers 5Ј-cagagcatggacagggagcaa-3Ј and 5Ј-gcaactcctcatggctgaggtctc-3Ј (20) . All PCR reactions were run at 95 C for 2 min followed by 35 cycles of 95 C for 30 s, 60 C for 45 s, 72 C for 60 s, and final extension at 72 C for 7 min. The PCR products were digested with ApaI (10 U at 37 C) or TaqI (3 U at 65 C) and electrophoresed in a 1.5% ethidium bromide-agarose gel. 
Parathyroid cells
Parathyroid adenoma cells were suspended enzymatically as previously described (21) . PTH release was evaluated by duplicate incubations of 0.5-1.0 ϫ 10 6 cells for 60 min at 37 C in 0.5 mL of a 25 mmol/L HEPES buffer (pH 7.4) containing 3 mmol/L glucose and 0.1% human serum albumin (21 ANOVA and Student's unpaired two-tailed t test were used for statistical evaluation, with P Ͻ 0.05 considered significant. All results are expressed as the mean Ϯ sem.
Results
VDR genotype distributions coincided with previous studies of HPT patients (Table 1 ) and contrasted with the underlying Swedish population demonstrating prevalences of 33% (bb), 21% (aa), and 34% (TT) (17, 18) . Consistent with other reports (15, 20) , concordance between the presence of the Bsm 1 and ApaI restriction sites and Bsm 1 and absence of TaqI was 74.2% and 98.4%, respectively. No significant association between genotypes and age, serum calcium or intact PTH, or parathyroid adenoma weight was recorded.
The characteristic sigmoidal suppression of PTH release in response to external Ca 2ϩ exhibited an expected mean increase in ED 50 to 1.59 Ϯ 0.07 mmol/L and a decreased maximal PTH suppression of 45 Ϯ 2.3% (4). ED 50 in each genotype was highest for the aa (P Ͻ 0.05, by ANOVA), bb (P ϭ 0.09), and TT (P ϭ 0.09) allelic pairs, whereas the heterozygotes demonstrated intermediate values (Fig. 1) 
Discussion
The recent demonstration of increased prevalence of the polymorphic VDR alleles b, a, and T in sporadic primary HPT supports interaction in the largely unknown tumorigenesis of this disorder (17) (18) (19) . In addition to influences on the risk of developing HPT, these polymorphisms currently are linked to Ca 2ϩ regulation of PTH release. Homozygosity for VDR alleles b, a, and T and the baT haplotype were associated with greater increases in ED 50 and lesser suppression of PTH release. It is tempting to speculate that this relationship depends on hampered regulatory actions of calcitriol from relatively reduced VDR expression in the parathyroid adenomas. Observations of approximately 30% lesser reporter gene activity upon insertion of the baT vs. the BAt haplotype into a minigene construct supports this idea (15) . However, any influence of these polymorphisms on VDR transcription and/or its mRNA stability in human parathyroid glands is purely speculative. Nevertheless, the VDR genotypes were apparently unrelated to parathyroid [Ca 2ϩ ] i . Any allelerelated effect on PTH secretion consequently seems to involve actions other than the Ca 2ϩ -sensing proteins on the parathyroid cell surface (5). This hypothesis is consistent with the demonstration that calcitriol interferes with PTH gene transcription (12) , but not parathyroid [Ca 2ϩ ] i or calcium receptor mRNA levels (9, 24) .
A variety of circumstances may confound the current observations. The examined VDR polymorphisms may be linked to additional polymorphisms in the VDR gene and/or to other genes of importance to parathyroid cell functions. Furthermore, the B/b alleles have been related to circulating calcitriol levels and PTH responses after the administration of calcitriol in healthy premenopausal females (15, 25) . Patients with the baT haplotype indeed demonstrated no apparent discrepancy with respect to serum Ca 2ϩ and PTH levels despite the fact that PTH secretion in vitro was less Ca 2ϩ sensitive. Circulating PTH levels, however, may also reflect the parathyroid tissue weight and perhaps even the rate of cell proliferation (26) , and serum calcium depends on a variety of factors, including peripheral actions of PTH and calcitriol. Several components, thus, may balance the consequences of any influence of polymorphic VDR alleles on PTH secretory regulation in vivo. 
